Clinical trial
Differential EBI2 Expression Upon Allelic Status of the rs9557195 Polymorphism
NCT03633409 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Differential EBI2 Expression Upon Allelic Status of the rs9557195 Polymorphism
- Lead sponsor
- University of Zurich
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 1, 2017
- Completion date
- December 1, 2018
- Enrollment
- 340 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.